TRUEX PAUL F 4
4 · CymaBay Therapeutics, Inc. · Filed Jan 31, 2019
Insider Transaction Report
Form 4
TRUEX PAUL F
Director
Transactions
- Award
Stock Option (right to buy)
2019-01-29+27,705→ 27,705 totalExercise: $8.43Exp: 2029-01-28→ Common Stock (27,705 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the underlying shares monthly from January 1, 2019.